Cardioembolic Stroke in Atrial Fibrillation-Rationale for Preventive Closure of the Left Atrial Appendage.
10.4070/kcj.2009.39.11.443
- Author:
Boris LEITHAUSER
1
;
Jai Wun PARK
Author Information
1. Asklepios General Hospital Harburg, 1st Medical Department, Cardiology, Intensive Care Medicine, Hamburg, Germany. j.park@asklepios.com
- Publication Type:Review
- Keywords:
Atrial appendage;
Atrial fibrillation;
Thromboembolism;
Stroke;
Prostheses and implants;
Prognosis
- MeSH:
Aged;
Arrhythmias, Cardiac;
Atrial Appendage;
Atrial Fibrillation;
Hemorrhage;
Humans;
Prognosis;
Prostheses and Implants;
Stroke;
Systole;
Thromboembolism;
Thrombosis;
Warfarin
- From:Korean Circulation Journal
2009;39(11):443-458
- CountryRepublic of Korea
- Language:English
-
Abstract:
Atrial fibrillation is the most common cardiac arrhythmias, and a major cause of morbidity and mortality due to cardioembolic stroke. The left atrial appendage is the major site of thrombus formation in non-valvular atrial fibrillation. Loss of atrial systole in atrial fibrillation and increased relative risk of associated stroke point strongly toward a role for stasis of blood in left atrial thrombosis, although thrombus formation is multifactorial, and much more than blood flow irregularities are implicated. Oral anticoagulation with vitamin-K-antagonists is currently the most effective prophylaxis for stroke in atrial fibrillation. Unfortunately, this treatment is often contraindicated, particularly in the elderly, in whom risk of stroke is high. Moreover, given the risk of major bleeding, there is reason to be skeptical of the net benefit when warfarin is used in those patients. This work reviews the pathophysiology of cardioembolic stroke and critically spotlights the current status of preventive anticoagulation therapy. Various techniques to exclude the left atrial appendage from circulation were discussed as a considerable alternative for stroke prophylaxis.
